Is Cidara Therapeutics, Inc. (CDTX) a Buy, Sell, or Hold?
Cidara Therapeutics, Inc.
NASDAQ:CDTX
$221.38 USD
$0 (0.0%)
- Volume
- 2.69M
- Average Volume
- 1.37M
- Market Capitalization
- $5.61B
- P/E Ratio
- -34.54
- Dividend Yield
- 0.00%
- Price Target
- $170.00
- Year High
- $221.42
- Year Low
- $15.22
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.62
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Jeffrey L. Stein |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | CDTX |
| CUSIP | 171757206 |
| CIK | 0001610618 |
| Web | https://www.cidara.com |
| Phone | 858 752 6170 |
| Currency | USD |
| Employees | 38 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 4.62 |
| Quick Ratio | 4.62 |
| Cash Ratio | 3.06 |
Sales & Book Value
| Annual Sales | $1.28M |
| Price / Sales | 0.00 |
| Cash Flow | -6.66 |
| Price / Cash Flow | -54.23 |
| Price / Book | 8.15 |
Price Target and Rating
| Average Stock Price Forecast | $170.00 |
| High Stock Price Forecast | $221.50 |
| Low Stock Price Forecast | $150.00 |
| Forecast Upside/Downside | 30.22% |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 11 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-26.75 |
| Trailing P/E Ratio | -34.54 |
| PEG Ratio | -1.17 |
| P/E Growth | -1.17 |
| Net Income | $-169.83M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | -37.30% |
| Return on Assets | -25.53% |
Financials Score
| AltmanZ Score | 32.61 |
| Piotroski Score | 2.00 |
| Working Capital | 346.98M |
| Total Assets | 518.65M |
| Ebit | -184.8M |
| Market Cap | 5.61B |
| Total Liabilities | 96.26M |
Poll Results
About Cidara Therapeutics, Inc. (NASDAQ:CDTX) Stock
Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen be ... hind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Frequently Asked Questions
-
What is the current Cidara Therapeutics, Inc. (CDTX) stock price?
-
Cidara Therapeutics, Inc.(NASDAQ:CDTX) stock price is $221.38 in the last trading session. During the trading session, CDTX stock reached the peak price of $221.42 while $15.22 was the lowest point it dropped to. The percentage change in CDTX stock occurred in the recent session was 0.0% while the dollar amount for the price change in CDTX stock was $0.
-
CDTX's industry and sector of operation?
-
The NASDAQ listed CDTX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of CDTX?
-
Jeffrey L. Stein | President, Chief Executive Officer & Executive Director
Preetam Shah | Principal Accounting Officer
Kevin Forrest | Founder & Chief Strategy Officer
Nicole Davarpanah | Chief Medical Officer
Jim Beitel | Chief Business Officer -
How many employees does CDTX have?
-
Number of CDTX employees currently stands at 38. CDTX operates from 6310 Nancy Ridge Drive, San Diego, CA 92121, US.
-
Link for CDTX official website?
-
Official Website of CDTX is: https://www.cidara.com
-
How do I contact CDTX?
-
CDTX could be contacted at phone #858 752 6170 and can also be accessed through its website. CDTX operates from 6310 Nancy Ridge Drive, San Diego, CA 92121, US.
-
How many shares of CDTX are traded daily?
-
The average number of CDTX shares traded daily for last 3 months was 1.37M.
-
What is the market cap of CDTX currently?
-
The market value of CDTX currently stands at $5.61B with its latest stock price at $221.38